newsfilter
← Latest News
GlobeNewswire·

Kamada Highlights CYTOGAM® Study Results Presented at the 2026 ISHLT Annual Meeting

REHOVOT, Israel and HOBOKEN, N.J., July 13, 2026 (GLOBE NEWSWIRE) -- Kamada Ltd. (NASDAQ:KMDA, TASE: KMDA.TA)), a global biopharmaceutical company with a portfolio of marketed products indicated for rare and serious